575 related articles for article (PubMed ID: 16769917)
1. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
3. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.
Moss AJ; Greenberg H; Case RB; Zareba W; Hall WJ; Brown MW; Daubert JP; McNitt S; Andrews ML; Elkin AD;
Circulation; 2004 Dec; 110(25):3760-5. PubMed ID: 15583079
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
[TBL] [Abstract][Full Text] [Related]
8. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
9. Defibrillator implantation early after myocardial infarction.
Steinbeck G; Andresen D; Seidl K; Brachmann J; Hoffmann E; Wojciechowski D; Kornacewicz-Jach Z; Sredniawa B; Lupkovics G; Hofgärtner F; Lubinski A; Rosenqvist M; Habets A; Wegscheider K; Senges J;
N Engl J Med; 2009 Oct; 361(15):1427-36. PubMed ID: 19812399
[TBL] [Abstract][Full Text] [Related]
10. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
[TBL] [Abstract][Full Text] [Related]
11. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.
Lee DS; Krahn AD; Healey JS; Birnie D; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
J Am Coll Cardiol; 2010 Feb; 55(8):774-82. PubMed ID: 20170816
[TBL] [Abstract][Full Text] [Related]
13. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
15. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
Marijon E; Trinquart L; Otmani A; Leclercq C; Fauchier L; Chevalier P; Klug D; Defaye P; Lellouche N; Mansourati J; Deharo JC; Sadoul N; Anselme F; Maury P; Davy JM; Extramiana F; Hidden-Lucet F; Probst V; Bordachar P; Mansour H; Chauvin M; Jouven X; Lavergne T; Chatellier G; Le Heuzey JY;
Am Heart J; 2010 Apr; 159(4):659-664.e1. PubMed ID: 20362726
[TBL] [Abstract][Full Text] [Related]
16. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
[TBL] [Abstract][Full Text] [Related]
17. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML;
J Am Coll Cardiol; 2007 Apr; 49(13):1427-33. PubMed ID: 17397670
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
[TBL] [Abstract][Full Text] [Related]
20. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
